Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index; 10 of the 32 sources its claims cite were checked for support.
Abstract
The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia. In this study, we purified RUNX-1-containing multiprotein complexes from phorbol ester-induced L8057 murine megakaryoblastic cells and identified the ets transcription factor FLI-1 as a novel in vivo-associated factor. The interaction occurs via direct protein-protein interactions and results in synergistic transcriptional activation of the c-mpl promoter. Interestingly, the interaction fails to occur in uninduced cells. Gel filtration chromatography confirms the differentiation-dependent binding and shows that it correlates with the assembly of a complex also containing the key megakaryocyte transcription factors GATA-1 and Friend of GATA-1 (FOG-1). Phosphorylation analysis of FLI-1 with uninduced versus induced L8057 cells suggests the loss of phosphorylation at serine 10 in the induced state. Substitution of Ser10 with the phosphorylation mimic aspartic acid selectively impairs RUNX-1 binding, abrogates transcriptional synergy with RUNX-1, and dominantly inhibits primary fetal liver megakaryocyte differentiation in vitro. Conversely, substitution with alanine, which blocks phosphorylation, augments differentiation of primary megakaryocytes. We propose that dephosphorylation of FLI-1 is a key event in the transcriptional regulation of megakaryocyte maturation. These findings have implications for other cell types where interactions between runx and ets family proteins occur.
Overview
CoChat Summary
TL;DR
This paper identifies FLI-1 as a novel direct RUNX-1 binding partner in megakaryocytic cells and shows that their differentiation-dependent interaction synergistically activates megakaryocyte gene transcription. It proposes that dephosphorylation of FLI-1 at Ser10 during terminal maturation promotes RUNX-1–FLI-1 complex assembly and megakaryocyte differentiation.
Key findings
- RUNX-1 multiprotein complexes purified from TPA-induced L8057 murine megakaryoblastic cells contained FLI-1; the interaction was direct by GST pulldown and occurred via protein-protein contacts rather than DNA/RNA-linked intermediates.
- RUNX-1/CBF-β plus FLI-1 synergistically activated the c-mpl promoter reporter: 31.2-fold over vector alone versus 2.2-fold for RUNX-1/CBF-β alone and 9.6-fold for FLI-1 alone; with GATA-1/FOG-1 included, activity was 75-fold versus 11.9-fold and 17.7-fold, respectively.
- The interaction was differentiation-dependent: little RUNX-1–FLI-1 binding occurred in uninduced L8057 cells, while TPA induction produced a large >669 kDa complex containing RUNX-1, FLI-1, GATA-1, and FOG-1.
- MS detected FLI-1 phosphorylation at seven sites in uninduced cells (Ser10, Ser13, Thr35, Ser37, Ser39, Ser79, Ser241) but only six in induced cells, with loss of Ser10; FLI-1S10D impaired RUNX-1 binding and abrogated transcriptional synergy, while FLI-1S10A enhanced primary megakaryocyte differentiation (CD41+/CD42b+ cells greater than wild type, P < 0.02) and FLI-1S10D inhibited it (P < 0.01).
Methods
- Tandem FLAG–streptavidin affinity purification of biotin-tagged RUNX-1 from TPA-induced L8057 cells followed by LC-MS/MS; validation by co-IP, GST pulldown, and domain mapping in 293T/COS-7 cells.
- Gel filtration chromatography, 2-D gel electrophoresis, and MS phosphorylation analysis; luciferase reporter assays using the murine c-mpl promoter; ChIP in induced L8057 cells and primary murine fetal liver megakaryocytes.
- Retroviral overexpression of wild-type, S10A, or S10D FLI-1 in E13.5 fetal liver megakaryocyte precursors cultured with TPO, with flow cytometric assessment of CD41/CD42b coexpression.
Limitations
- The paper states that it cannot exclude effects of the Ser10 mutations unrelated to phosphorylation or RUNX-1 binding; it also notes insufficient cells to confirm equivalent protein expression of the different constructs, and that the mechanism by which Ser10 phosphorylation inhibits RUNX-1 binding, as well as the responsible kinase(s)/phosphatase(s), remains unclear.
- The paper states that it cannot conclude that loss of RUNX-1–FLI-1 interaction causes abnormal hematopoiesis in patients with the tested RUNX-1 mutations.
- Evident from the text: several interaction-mapping inputs were not visualized by Western blotting, and key biochemical assays used heterologous cells or the L8057 cell line; the primary megakaryocyte differentiation experiments relied on retroviral overexpression rather than endogenous FLI-1 mutation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 0 Not valid · 9 Not checked · 73 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The latter cause of death is due to a defect in the emergence of hematopoietic stem cells from the aorta-gonadal-mesonephros region during embryogenesis”
§ Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development[▿](#fn2)[§](#fn1) > Abstract
What the sources say
- Partly supportedcites [31] Mukouyama, Y., N. Chiba, T. Hara, H. Okada, Y. Ito, R. Kanamaru, A. Miyajima, M. Satake, and T. Watanabe. 2000. The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region. Dev. Biol. 22027-36. [[DOI](https://doi.org/10.1006/dbio.2000.9617)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10720428/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Dev.%20Biol.&volume=220&publication_year=2000&pages=27&pmid=10720428&doi=10.1006/dbio.2000.9617&)] sourceExperimental — accuracy not yet measured
Our copy supports the causal core: in 'Hematopoietic Activity in the P-Sp/AGM Region of AML1-Targeted Embryos' the authors state that the lack of hematopoiesis in the liver of AML1(−/−) embryos 'is actually preceded by a defect in hematopoiesis in the P-Sp/AGM region,' and in 'No Hematopoietic Activity in the P-Sp/AGM Region' they rule out failed migration/settling in favour of progenitors not being generated in the P-Sp/AGM. However, the evidence is CFU-C progenitor activity and hematopoietic-marker flow cytometry — no long-term-repopulating stem-cell assay is reported, so the claim's specificity ('emergence of hematopoietic stem cells') outruns what the paper measured; the Introduction's LTR-HSC-in-AGM statements are background citations to Medvinsky/Dzierzak, not this paper's data. The paper also qualifies the picture: 'Hematogenic Precursors Still Persist in 9.5-dpc Embryos but Are Lost from 11.5 dpc' shows inert but competent hematogenic precursors remain in AML1(−/−) endothelial-like cells and are partly restored by AML1 cDNA, i.e. a requirement for development/maintenance rather than a simple failure of stem-cell emergence. (LLM, conf=0.72)
- Not checked yetcites [34] North, T., T. L. Gu, T. Stacy, Q. Wang, L. Howard, M. Binder, M. Marin-Padilla, and N. A. Speck. 1999. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 1262563-2575. [[DOI](https://doi.org/10.1242/dev.126.11.2563)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10226014/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Development&volume=126&publication_year=1999&pages=2563&pmid=10226014&doi=10.1242/dev.126.11.2563&)] source
- Not checked yetcites [64] Yokomizo, T., M. Ogawa, M. Osato, T. Kanno, H. Yoshida, T. Fujimoto, S. Fraser, S. Nishikawa, H. Okada, M. Satake, T. Noda, and Y. Ito. 2001. Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells 613-23. [[DOI](https://doi.org/10.1046/j.1365-2443.2001.00393.x)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11168593/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Genes%20Cells&volume=6&publication_year=2001&pages=13&pmid=11168593&doi=10.1046/j.1365-2443.2001.00393.x&)] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
§ Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development[▿](#fn2)[§](#fn1) > Abstract
What the sources say
- Supportedcites [14] Growney, J. D., H. Shigematsu, Z. Li, B. H. Lee, J. Adelsperger, R. Rowan, D. P. Curley, J. L. Kutok, K. Akashi, I. R. Williams, N. A. Speck, and D. G. Gilliland. 2005. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106494-504. [[DOI](https://doi.org/10.1182/blood-2004-08-3280)] [[PMC free article](/articles/PMC1895175/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/15784726/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood&volume=106&publication_year=2005&pages=494&pmid=15784726&doi=10.1182/blood-2004-08-3280&)] source
The Discussion states directly that 'Runx1 is required for normal maturation of the megakaryocyte lineage but not for the establishment of this lineage,' backed by the Results section 'Effects of Runx1 excision on the myeloid lineage' (~80% drop in platelet counts, marked decrease in mature megakaryocytes, reduced polyploidization; p < .034 for megakaryocyte colony changes). The Introduction covers the second half of the sentence: 'Several lines of evidence suggest that loss-of-function mutations in RUNX1 contribute to the pathogenesis of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML),' including FPD/AML from RUNX1 loss-of-function mutations and sporadic mutations in ~3%-5% of leukemias and at lower frequency in MDS. Minor scope note: the megakaryocyte requirement is demonstrated by conditional Runx1 excision in adult mouse hematopoiesis rather than in human megakaryocytes, but the paper states the requirement generally. (LLM, conf=0.85)
- Not checked yetcites [18] Ichikawa, M., T. Asai, T. Saito, G. Yamamoto, S. Seo, I. Yamazaki, T. Yamagata, K. Mitani, S. Chiba, H. Hirai, S. Ogawa, and M. Kurokawa. 2004. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10299-304. [[DOI](https://doi.org/10.1038/nm997)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/14966519/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&volume=10&publication_year=2004&pages=299&pmid=14966519&doi=10.1038/nm997&)] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Conditional knockout studies of mice demonstrate a specific role for RUNX-1 in megakaryocyte differentiation during adult stages of hematopoiesis”
§ Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development[▿](#fn2)[§](#fn1) > Abstract
What the sources say
- Supportedcites [14] Growney, J. D., H. Shigematsu, Z. Li, B. H. Lee, J. Adelsperger, R. Rowan, D. P. Curley, J. L. Kutok, K. Akashi, I. R. Williams, N. A. Speck, and D. G. Gilliland. 2005. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106494-504. [[DOI](https://doi.org/10.1182/blood-2004-08-3280)] [[PMC free article](/articles/PMC1895175/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/15784726/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood&volume=106&publication_year=2005&pages=494&pmid=15784726&doi=10.1182/blood-2004-08-3280&)] source
The Discussion (p. of section 'Discussion') states that in the conditional (Mx1-Cre–mediated, adult) Runx1-excised mice, 'Runx1 loss had no apparent effect on the erythroid lineage, but it did have a significant effect on megakaryocytic maturation. Runx1 is required for normal maturation of the megakaryocyte lineage but not for the establishment of this lineage.' The Abstract and the section 'Excision of a conditional Runx1 allele in adult hematopoietic tissues' corroborate the adult-stage conditional design and the megakaryocyte/platelet phenotype (inefficient platelet production, ~80% decrease in platelets), and 'Effects of Runx1 excision on the myeloid lineage' reports altered megakaryocyte colony maturation. (LLM, conf=0.90)
- Not checked yetcites [18] Ichikawa, M., T. Asai, T. Saito, G. Yamamoto, S. Seo, I. Yamazaki, T. Yamagata, K. Mitani, S. Chiba, H. Hirai, S. Ogawa, and M. Kurokawa. 2004. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10299-304. [[DOI](https://doi.org/10.1038/nm997)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/14966519/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&volume=10&publication_year=2004&pages=299&pmid=14966519&doi=10.1038/nm997&)] source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Haploinsufficiency of CBF-β also perturbs megakaryopoiesis in mice”
§ Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development[▿](#fn2)[§](#fn1) > Abstract
What the sources say
- Partly supportedcites [54] Talebian, L., Z. Li, Y. Guo, J. Gaudet, M. E. Speck, D. Sugiyama, P. Kaur, W. S. Pear, I. Maillard, and N. A. Speck. 2007. T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage. Blood 10911-21. [[DOI](https://doi.org/10.1182/blood-2006-05-021188)] [[PMC free article](/articles/PMC1785070/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/16940420/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood&volume=109&publication_year=2007&pages=11&pmid=16940420&doi=10.1182/blood-2006-05-021188&)] sourceExperimental — accuracy not yet measured
Our copy supports reduced CBFβ dosage perturbing megakaryopoiesis in mice, but at 30% and 15% of wild-type levels, not at haploinsufficient (single-copy, ~50%) dosage: the Introduction states megakaryocyte development is 'sensitive to reductions in CBFβ dosage to 30% and 15% of wild-type levels,' and the allelic series defines Cbfb+/− as 50% (Results, Figure 1D passage). All megakaryocyte data reported are from Cbfbrss/− (15%) fetuses, the effect was 'observed only in vitro,' in vivo platelet counts were not significantly different (Table 1), and the authors hedge that CBFβ 'may be required for Runx1 function in megakaryocyte differentiation' (Results). The haploinsufficiency phenotype in these passages is credited to RUNX1 ('haploinsufficiency of RUNX1 causes a familial platelet disorder in humans'; megakaryocyte alterations 'reminiscent of those reported for Runx1 haploinsufficiency'), and the only CBFB-haploinsufficiency speculation in the Discussion concerns skeletal, not megakaryocyte, abnormalities. (LLM, conf=0.78)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“abrogates transcriptional synergy with RUNX-1”
§ Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development[▿](#fn2)[§](#fn1) > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
51 more claims
Create a free account to see all 90 claims and to verify the 22 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“RUNX1 physically interacts with PU.1, CEBPA, GATA1, GATA2, PAX5, FLI1, and ETS1.4–10,13”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The transcription factor (TF) RUNX1 cooperates with lineage-specifying TFs (eg, PU.1/SPI1) to activate myeloid differentiation genes, such as macrophage and granulocyte macrophage colony-stimulating factor receptors (MCSFR and GMCSFR).”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“RUNX1 synergistically augments transcription activation by multiple hematopoietic lineage specifying transcription factors: PU.1, CEBPA, ETS1, GATA1, GATA2, FLI1, PAX5, SCL, and ERG”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“RUNX1 synergistically increases transcriptional activation by ETS1, PU.1(SPI1), CCAAT/enhancer binding protein-α (CEBPA), GATA1, GATA2, and FLI1.4–10”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“However, RUNX1 potently enhances gene activation by multiple key hematopoietic lineage-specifying TFs.4–10”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development[▿](#fn2)[§](#fn1) > RESULTS > TPA-induced dephosphorylation of FLI-1.
“phosphorylation analysis of endogenous FLI-1 from uninduced rather than induced L8057 cells was performed.”
§ Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development[▿](#fn2)[§](#fn1) > RESULTS > TPA-induced dephosphorylation of FLI-1.
“However, only six of these sites (Ser13, Thr35, Ser37, Ser39, Ser79, and Ser241) were detected from induced cells.”
Citations
Cites
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 4×
“As each peptide was eluted, they were subjected to electrospray ionization and fed into an LTQ linear ion trap MS (Thermo Scientific).”
MethodInfluentialOkuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856 · cited 1×
“5 due to central nervous system hemorrhage and failure of all definitive hematopoiesis (38, 59).”
BackgroundWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178 · cited 1×
“5 due to central nervous system hemorrhage and failure of all definitive hematopoiesis (38, 59).”
BackgroundSong, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100 · cited 1×
“Germ line mutations in RUNX-1 cause familial platelet disorder with the propensity to develop acute myelogenous leukemia (FPD/AML), a rare autosomal dominant disorder characterized by quantitative and qualitative platelet defects and a high incidence of developing myelodysplastic syndrome (MDS) and leukemia (40, 48).”
BackgroundStepwise Reprogramming of B Cells into Macrophages
Xie, H., Ye, M., Feng, R., & Graf, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00419-2 · Cited by 947
Avecilla, S. T., Hattori, K., Heissig, B., Tejada, R., Liao, F., Shido, K., Jin, D. K., Dias, S., Zhang, F., Hartman, T. E., et al. (2004) · Nature Medicine · doi:10.1038/nm973 · Cited by 790
Shivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., & Orkin, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90531-6 · Cited by 693
Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674
Cbfa2 is required for the formation of intra-aortic hematopoietic clusters
North, T., Gu, T.-L., Stacy, T., Wang, Q., Howard, L., Binder, M., Marín-Padilla, M., & Speck, N. A. (1999) · Development · doi:10.1242/dev.126.11.2563 · Cited by 662
Dynamic Visualization of Thrombopoiesis Within Bone Marrow
Junt, T., Schulze, H., Chen, Z., Massberg, S., Goerge, T., Krueger, A., Wagner, D. D., Graf, T., Italiano, J. E., Shivdasani, R. A., et al. (2007) · Science · doi:10.1126/science.1146304 · Cited by 652
Cited by
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“However, other ETS proteins such as ELF2, ELF4, and FLI1 have been reported to interact with RUNX proteins (160, 161).”
Tijssen, M. R., Cvejic, A., Joshi, A., Hannah, R. L., Ferreira, R., Forrai, A., Bellissimo, D. C., Oram, S. H., Smethurst, P. A., Wilson, N. K., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.04.008 · Cited by 289
“Our combinatorial binding data are therefore consistent with a model where additional factors such as RUNX1 mediate transcriptional cooperation between GATA1 and FLI1 in MKs whereas antagonistic interactions may prevail in their absence as previously reported for the erythroid lineage.”
InfluentialThrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation
Bluteau, D., Balduini, A., Balayn, N., Currao, M., Nurden, P., Deswarte, C., Leverger, G., Noris, P., Perrotta, S., Solary, E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71861 · Cited by 202
“RUNX1, FLI1, SCL, GATA1, and GATA2 are known coregulators of megakaryopoiesis (12, 19) that simultaneously bind promoter regions of key regulators of MK differentiation and functions (19).”
Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling
Tang, X., Hou, Y., Yang, G., Wang, X., Tang, S., Du, Y.-E., Yang, L., Yu, T., Zhang, H., Zhou, M., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.78 · Cited by 200
Lordier, L., Bluteau, D., Jalil, A., Legrand, C., Pan, J., Rameau, P., Jouni, D., Bluteau, O., Mercher, T., Leon, C., et al. (2012) · Nature Communications · doi:10.1038/ncomms1704 · Cited by 170
“As these two transcription factors may be associated with RUNX1 in large transcription complexe”
BackgroundRUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis
Lam, K. (2012) · Frontiers in Bioscience · doi:10.2741/3977 · Cited by 167
“1, C/EBPalpha, p300, mSin3a, GATA1, and Fli1 among many other factors that will not be further discussed in this review (42-47).”
BackgroundStockley, J., Morgan, N. V., Bem, D., Lowe, G., Lordkipanidzé, M., Dawood, B. B., Simpson, M. A., Macfarlane, K., Horner, K., Leo, V., et al. (2013) · Blood · doi:10.1182/blood-2013-06-506873 · Cited by 139
RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation
Kuvardina, O. N., Herglotz, J., Kolodziej, S., Kohrs, N., Herkt, S., Wojcik, B., Oellerich, T., Corso, J., Behrens, K., Kumar, A., et al. (2015) · Blood · doi:10.1182/blood-2014-11-610519 · Cited by 123
Geddis, A. E. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.03.001 · Cited by 163
Regulation of endothelial cell development by ETS transcription factors
Meadows, S. M., Myers, C. T., & Krieg, P. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.009 · Cited by 107
MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations
Antony‐Debré, I., Bluteau, D., Itzykson, R., Baccini, V., Renneville, A., Boehlen, F., Morabito, M., Droin, N. M., Deswarte, C., Chang, Y., et al. (2012) · Blood · doi:10.1182/blood-2012-04-422352 · Cited by 91
ETS transcription factors in hematopoietic stem cell development
Ciau‐Uitz, A., Wang, L., Patient, R. K., & Liu, F. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.07.010 · Cited by 81
Chlon, T. M., Doré, L. C., & Crispino, J. D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.051 · Cited by 72
“Indeed, several previous studies have shown that GATA-1, FOG-1, and the ETS protein FLI-1 exist in transcriptional complexes at megakaryocyte genes (Huang et al., 2009; Pang et al., 2006; Wang et al., 2002; Woo et al., 2008).”
BackgroundHuang, H., Woo, A. J., Waldon, Z., Schindler, Y., Moran, T. B., Zhu, H. H., Feng, G.-S., Steen, H., & Cantor, A. B. (2012) · Genes & Development · doi:10.1101/gad.192054.112 · Cited by 70
“It is a central component of a dynamic combinatorial transcription factor network that includes GATA1/2, FLI1, TAL/SCL, and AP1 (Elagib et al. 2003; Huang et al. 2009; Wilson et al. 2010; Palii et al. 2011; Pencovich et al. 2011; Tijssen et al. 2011).”
BackgroundMethodInfluentialSelf-citationEmmanuel, A. O., Arnovitz, S., Haghi, L., Mathur, P., Mondal, S., Quandt, J., Okoreeh, M. K., Maienschein‐Cline, M., Khazaie, K., Dose, M., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0254-4 · Cited by 73
Choudhary, N., & Singh, V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191006 · Cited by 79
The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis
Muskens, I. S., Li, S., Jackson, T., Elliott, N., Hansen, H. M., Myint, S. S., Pandey, P., Schraw, J. M., Roy, R., Anguiano, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21064-z · Cited by 66
RUNX1 regulates corepressor interactions of PU.1
Hu, Z., Gu, X., Baraoidan, K., Ibanez, V., Sharma, A., Kadkol, S., Munker, R., Ackerman, S., Nucifora, G., & Saunthararajah, Y. (2011) · Blood · doi:10.1182/blood-2010-10-312512 · Cited by 63
Bergiers, I., Andrews, T. S., Bölükbaşı, Ö. V., Buneß, A., Janosz, E., López-Anguita, N., Ganter, K., Kosim, K., Celen, C., Perçin, G. I., et al. (2018) · eLife · doi:10.7554/elife.29312 · Cited by 62
“On the other hand, Fli1 could switch its function upon physical interaction with Runx1, as shown during megakaryocytic differentiation where there is a synergistic transcrip- tional activation upon Fli1–Runx1 interaction (Huang et al., 2009).”
BackgroundTargeting the CALR interactome in myeloproliferative neoplasms
Pronier, E., Cifani, P., Merlinsky, T. R., Berman, K. B., Somasundara, A. V. H., Rampal, R. K., LaCava, J., Wei, K. E., Pastore, F., Mååg, J. L. V., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122703 · Cited by 61
Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion
Little, G. H., Noushmehr, H., Baniwal, S. K., Berman, B. P., Coetzee, G. A., & Frenkel, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1219 · Cited by 69
Current insights into the role of Fli-1 in hematopoiesis and malignant transformation
Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04160-1 · Cited by 54
“Binding of FLI1 to RUNX1 strictly depends on loss of phosphorylation of serine 10 on the FLI1 protein [32].”
BackgroundAcute myeloid leukemia: A central role for the ETS factor ERG
Martens, J. H. A. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.014 · Cited by 57
Guo, T., Wang, X., Qu, Y., Yin, Y., Jing, T., & Zhang, Q. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2306-9759.2015.02.01 · Cited by 68
“Fli-1 is a member of the ETS family of winged helixturn-helix transcription factors that bind a purine-rich consensus sequence, GGA (A/T).”
BackgroundInfluentialStarck, J., Weiss‐Gayet, M., Gonnet, C., Guyot, B., Vicat, J.-M., & Morlé, F. (2010) · Blood · doi:10.1182/blood-2010-02-270405 · Cited by 57
The Ewing's sarcoma fusion protein, EWS‐FLI, binds Runx2 and blocks osteoblast differentiation
Li, X., McGee‐Lawrence, M. E., Decker, M., & Westendorf, J. J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22782 · Cited by 46
“FLI1 also physically associates with RUNX1 to regulate gene expression in certain contexts [Huang et al., 2009].”
BackgroundTranscription factor defects causing platelet disorders
Daly, M. E. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.07.002 · Cited by 51
“[30,31], and with C/EBP factors to activate the macrophage colonystimulating factor receptor promoter [32], and several proteins have been identified that interact with motifs in the C terminus of RUNX1 to mediate its activities [27].”
BackgroundGobert, V., Osman, D., Bras, S., Augé, B., Boube, M., Bourbon, H.-M. G., Horn, T. L., Boutros, M., Haenlin, M., & Waltzer, L. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01625-09 · Cited by 47
“Similarly in mammals, GATA1 and RUNX1 are both involved in megakaryopoiesis and synergize to activate the transcription of megakaryocytic promoters in cultured cells (25, 37, 72).”
BackgroundMethodLandrette, S. F., Madera, D., He, F., & Castilla, L. H. (2011) · Leukemia · doi:10.1038/leu.2010.301 · Cited by 37
Liu, T., Yao, Y., Zhang, G., Wang, Y., Deng, B., Song, J., Li, X., Han, F., Xiao, X., Yang, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14377 · Cited by 36
“Fli-1 has been shown to interact with RUNX1, and TPA reduces phosphorylation of serine-10 residue in Fli-1 that was found to be critical for this complex to promote megakaryocytic differentiation [49].”
BackgroundGu, X., Hu, Z., Ebrahem, Q., Crabb, J. S., Mahfouz, R. Z., Radivoyevitch, T., Crabb, J. W., & Saunthararajah, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.562447 · Cited by 42
Blood platelet formation at a glance
Boscher, J., Guinard, I., Eckly, A., Lanza, F., & Léon, C. (2020) · Journal of Cell Science · doi:10.1242/jcs.244731 · Cited by 32
“Together, the proto-oncogene friend leukemia integration 1 (FLI1) and GATA1 activate specific genes responsible for the regulation of late MK progenitor cells (Huang et al., 2009).”
BackgroundTranscription factor‐mediated reprogramming toward hematopoietic stem cells
Ebina, W., & Rossi, D. J. (2015) · The EMBO Journal · doi:10.15252/embj.201490804 · Cited by 43
“In addition to recruiting cofactors, TFs often bind cooperatively to DNA as components of multiprotein complexes (Huang et al , 2009; Ravasi et al , 2010; Kazemian et al , 2013).”
Moussa, O., LaRue, A. C., Abangan, R. S., Williams, C. R., Zhang, X. K., Masuya, M., Gong, Y. Z., Spyropoulos, D. D., Ogawa, M., Gilkeson, G. S., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01112-09 · Cited by 35
“While Runx1 and GATA-1 mRNA expression were not significantly different in total BM, we note a statistically significant decrease in these levels in the MKs of Fli1 CTA/Fli1 CTA mice.”
BackgroundInfluentialTEThered to Runx: Novel binding partners for runx factors
Li, X., Decker, M., & Westendorf, J. J. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.03.002 · Cited by 35
“[18]; thus, the FLI1 portion of fusion proteinmay increase the affinity of EWS–FLI to RUNX proteins as compared to EWSR1.”
Inherited thrombocytopenias: an approach to diagnosis and management
Geddis, A. E. (2012) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2012.01454.x · Cited by 37
Draper, J. E., Sroczyńska, P., Leong, H. S., Fadlullah, M. Z. H., Miller, C. J., Kouskoff, V., & Lacaud, G. (2017) · Blood · doi:10.1182/blood-2016-06-723635 · Cited by 34
Molecular basis of inherited thrombocytopenias
Savoia, A. (2015) · Clinical Genetics · doi:10.1111/cge.12607 · Cited by 36
“Like ETV6, FLI1 is a member of the ETS family and cooperates with RUNX1 during megakaryopoiesis (35).”
BackgroundToscano, M. G., Navarro-Montero, Ó., Ayllón, V., Ramos–Mejía, V., Guerrero-Carreno, X., Bueno, C., Romero, T., Lamolda, M., Cobo, M., Martín, F., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.196 · Cited by 30
Tober, J. M., Maijenburg, M. W., & Speck, N. A. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.01.008 · Cited by 31
Lichtinger, M., Hoogenkamp, M., Krysinska, H., Ingram, R., & Bonifer, C. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.02.009 · Cited by 30
Huang, Y., Thoms, J. A. I., Tursky, M. L., Knezevic, K., Beck, D., Chandrakanthan, V., Suryani, S., Olivier, J., Boulton, A. M., Glaros, E. N., et al. (2016) · Leukemia · doi:10.1038/leu.2016.55 · Cited by 27
Sumoylation Regulates Interaction of FOG1 with C-terminal-binding Protein (CTBP)
Snow, J. W., Kim, J., Currie, C. R., Xu, J., & Orkin, S. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.096909 · Cited by 26
Ziyad, S., Riordan, J. D., Cavanaugh, A. M., Su, T., Hernandez, G. E., Hilfenhaus, G., Morselli, M., Huynh, K., Wang, K., Chen, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.017 · Cited by 18
“These genes have been implicated in pathological myelo-erythropoiesis and hematopoiesis in general, providing strong validation to the screen (Athanasiou et al., 2000; Huang et al., 2009; Zochodne et al., 2000).”
BackgroundRUNX3 Facilitates Growth of Ewing Sarcoma Cells
Bledsoe, K. L., McGee‐Lawrence, M. E., Camilleri, E. T., Wang, X., Riester, S. M., van Wijnen, A. J., Oliveira, A. M., & Westendorf, J. J. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24663 · Cited by 25
“This gene rearrangement creates a tumor-specific fusion protein, EWS/FLI, by joining the N-terminal transcriptional activation domain of the TET family protein, EWSR1, to the ETS DNA binding domain of transcription factor, FLI1.”
InfluentialNeuwirtová, R., Fuchs, O., Holická, M., Vostrý, M., Kostečka, A., Hajkova, H., Jonasova, A. T., Čermák, J., Čmejla, R., Pospíšilová, D., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1568-1 · Cited by 22
“Fli1 is active only if dephosphorylated [22].”
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
van der Kouwe, E., & Staber, P. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020350 · Cited by 29
Structural Basis for Dimerization and DNA Binding of Transcription Factor FLI1
Hou, C., & Tsodikov, O. V. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01121 · Cited by 21
Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells
Phillips, J. L., Taberlay, P. C., Woodworth, A. M., Hardy, K., Brettingham‐Moore, K. H., Dickinson, J. L., & Holloway, A. F. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26197 · Cited by 17
“…multiple regulatory layers involving interaction with other co-factors or transcription factors, distal regulatory elements and epigenetic factors (Bowers, Calero-Nieto, Valeaux, Fernandez-Fuentes, & Cockerill, 2010; Elagib et al., 2003; Huang et al., 2009; Reed-Inderbitzin et al., 2006).”
BackgroundApoptosis in megakaryocytes: Safeguard and threat for thrombopoiesis
Yang, S., Wang, L., Wu, Y., Wu, A., Huang, F., Tang, X., Kantawong, F., Anuchapreeda, S., Qin, D., Mei, Q., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1025945 · Cited by 29
“FLI1 and GATA-1 activate specific genes that regulate latestage MKPs (44).”
BackgroundTranscription factor Fli-1 as a new target for antitumor drug development
Li, L., Yu, J. H., Cheng, S., Peng, Z., & Luo, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.076 · Cited by 17
Lu, B., Sun, X., Chen, Y., Jin, Q., Liang, Q., Liu, S., Li, Y., Zhou, Y., Li, W., & Huang, Z. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1704-2 · Cited by 18
“In addition, we measured the expression of several transcription factors that played important roles in megakaryocyte differentiation [18–20].”
Okada, Y., Watanabe, M., Nakai, T., Kamikawa, Y., Shimizu, M., Fukuhara, Y., Yonekura, M., Matsuura, E., Hoshika, Y., Nagai, R., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12355 · Cited by 19
Pasupuleti, S. K., Chandrasekhar, C., Srikanth, L., & Sarma, P. V. G. K. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.090 · Cited by 11
NLS-tagging: an alternative strategy to tag nuclear proteins
Giraud, G., Stadhouders, R., Conidi, A., Dekkers, D. H. W., Huylebroeck, D., Demmers, J., Soler, É., & Grosveld, F. G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku869 · Cited by 11
“Moreover, we also found Fli1 to interact with the Run×1 TF, an interaction found to be important for megakaryopoiesis (27) (Figure 6a).”
GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development
Takasaki, K., & Chou, S. T. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_12 · Cited by 14
Genome wide mapping of ETV6 binding sites in pre-B leukemic cells
Neveu, B., Caron, M., Lagacé, K., Richer, C., & Sinnett, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-33947-1 · Cited by 13
Piper longum : A review of its phytochemicals and their network pharmacological evaluation
(2017) · doi:10.1101/169763 · Cited by 10
“4 (Ihlenfeldt et al., 2009).”
Yu, M., Mazor, T., Huang, H., Huang, H.-T., Kathrein, K. L., Woo, A. J., Chouinard, C. R., Labadorf, A., Akie, T. E., Moran, T. B., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.032 · Cited by 215
“The L8057-birA and L8057-FLAG-bio Runx-1 cell lines were generated and cultured as previously described (Huang et al., 2009).”
InfluentialSelf-citationThe genomic and proteomic blueprint of mouse megakaryocytes derived from embryonic stem cells
Merico, V., Zuccotti, M., Carpi, D., Baev, D. V., Mulas, F., Sacchi, L., Bellazzi, R., Pastorelli, R., Redi, C. A., Moratti, R., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04673.x · Cited by 9
Tyrosyl phosphorylation toggles a Runx1 switch
Neel, B. G., & Speck, N. A. (2012) · Genes & Development · doi:10.1101/gad.198051.112 · Cited by 7
Dual mechanism of inflammation sensing by the hematopoietic progenitor genome
Tran, V. L., Liu, P., Katsumura, K. R., Soukup, A. A., Kopp, A., Ahmad, Z. S., Mattina, A. E., Brand, M., Johnson, K. D., & Bresnick, E. H. (2025) · Science Advances · doi:10.1126/sciadv.adv3169 · Cited by 6
Yalcin, B. H., Macas, J., Wiercinska, E., Harter, P. N., Fawaz, M., Schmachtel, T., Ghiro, I., Bieniek, E., Kosanovic, D., Thom, S., et al. (2023) · Cells · doi:10.3390/cells12232765 · Cited by 6
“Our data support a scenario in which Wnt/ β -catenin acts upstream of RUNX1, shifting it to the protein–protein interaction with FLI1, which favors MK lineage differentiation and inhibits erythroid production [4,50].”
ResultLiu, H., Cui, Y. T., Wang, G., Dong, Q., Yao, Y., Li, P., Cao, C., & Liu, X. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.05.001 · Cited by 8
Choosing wisely: RUNX1 alternate promoter use
Cantor, A. B. (2017) · Blood · doi:10.1182/blood-2017-06-786228 · Cited by 5
“Prior work has shown that the major megakaryocyte transcription factor FLI1 cross-antagonizes the key erythroid-specific transcription factor KLF1 in this decision and that FLI1 physically and functionally cooperates with RUNX1.(8,9) Recent work by Kuvardina et al(10) showed that RUNX1 directly represses transcription…”
BackgroundSelf-citationHua, Q.-H., Zhang, X., Tian, R., She, Z., & Huang, Z. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2400127 · Cited by 5
“RUNX1 and FLI1 not only regulate the transition from mitosis to endomito‐ sis but also couple the arrest of DNA replication to megakaryocyte terminal differentiation (Huang H et al., 2009).”
Redox Regulation of Megakaryocyte Differentiation and Platelet Biogenesis
Chung, H., Shin, E., 박태호, Jeong, H., Jung, H., Bae, O.-N., & Noh, J. (2026) · Antioxidants · doi:10.3390/antiox15030352 · Cited by 4
Sharma, R., Gangwar, S. P., & Saxena, A. K. (2018) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x1801110x · Cited by 3
“…et al., 2003; Hendricks et al., 1999, 2003; Cheng et al., 2003; Kriegebaum et al., 2010), regulation of angiogenesis and megakaryocyte differentiation (Kruse et al., ISSN 2053-230X # 2018 International Union of Crystallography 2009; Huang et al., 2009; Craig et al., 2015; Jackers et al., 2004).”
BackgroundFLI1 and GATA1 govern TLN1 transcription: new insights into FLI1-related platelet disorders
Gabinaud, E., Hannouche, L., Veneziano-Broccia, M., Agthoven, J. F. V., Suffit, J., Maurizio, J., Potier, D., Payet‐Bornet, D., Bastelica, D., Andersen, E., et al. (2025) · Haematologica · doi:10.3324/haematol.2024.286372 · Cited by 6
Inefficient megakaryopoiesis in mouse hematopoietic stem–progenitor cells lacking T-bet
Furusawa, A., Sadashivaiah, K., Singh, Z. N., Civin, C. I., & Banerjee, A. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.11.003 · Cited by 2
Megakaryocytic Transcription Factors in Disease and Leukemia
Cantor, A. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_3 · Cited by 1
Self-citationNext-Generation Sequencing in the Study of Platelets
Leo, V. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_47 · Cited by 1
Karami, F., Kazemi, A., Nadali, F., Alizade, S., Faramarzi, A., Alijani, S., Minayi, N., Shahmoradi, H., & Farshi, Y. (2015) · Journal of Biology and Today s World · doi:10.15412/j.jbtw.01040701
Okyere, B. (2013) · VTechWorks (Virginia Tech)
The fetal pathogenesis of Down syndrome-associated leukaemias
Roy, A. (2010) · Spiral (Imperial College London) · doi:10.25560/12670
Singh, R., Rasheed, H., Ahmed, S., Singh, H., & Sharma, A. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166211-00148 · Cited by 2
The Role of DIAPH1 in the Megakaryopoiesis
Pan, J. (2014) · theses.fr (ABES) · doi:10.70675/3d0829d2zfc18z4bc0z8e26ze0030ccb042f
Saultier, P. (2018) · theses.fr (ABES) · doi:10.70675/82b23fb9zb1f8z48e6zae2az22fa5f0a8ba0 · Cited by 1
Cell fate decision and lineage specification mechanisms in hematopoiesis
Lee, I., Earth, Y., & Kang, Y.-A. (2026) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2026.06.001
The roles of RUNX1 in megakaryocyte differentiation in myeloid leukemia
Xie, Y., Ng, I., Liu, Y., Wang, H., & Yang, Q. (2026) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2026.2718439
Huang, J., Yin, X., Shi, X., Xiu-di, Y., Li, R., Zhang, X., Zhang, Y., Tong, H., Jin, J., & Huang, J. (2026) · Biomarker Research · doi:10.1186/s40364-026-01003-0
Metadata
- Authors
- Huang, H., Yu, M., Akie, T. E., Moran, T. B., Woo, A. J., Tu, N., Waldon, Z., Lin, Y. Y., Steen, H., & Cantor, A. B.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- Cantor, Alan B.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-08-01
- Volume
- 29
- Issue
- 15
- Pages
- 4103-4115
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2715817
- OpenAlex
- W2103532641
- Semantic Scholar
- 1cb0b0bddb87d3024415b77cbdd5924a12cf264b
- Cited by
- 87
- References
- 67
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 11 · 2017: 6 · 2016: 5 · 2015: 8 · 2014: 7 · 2013: 4 · 2012: 10
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- American Society of Hematology
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL082952)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- FLI1, megakaryopoiesis, protein-protein interaction, transcriptional synergy, GATA-1, FOG-1, dephosphorylation, transcriptional regulation, myelodysplastic syndrome, leukemia
- MeSH terms
- Animals, Cell Differentiation, Cell Line, Cells, Cultured, Electrophoresis, Polyacrylamide Gel, Humans, Liver, Megakaryocytes, Mice, Inbred C57BL, Models, Biological, Mutation, Phosphorylation, Protein Binding, Serine, Tetradecanoylphorbol Acetate, Gene Expression, Protein Interaction Mapping, Core Binding Factor Alpha 2 Subunit, Mice, Proto-Oncogene Protein c-fli-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.